Joint meeting of the Israeli Immunological Society (IIS) and Israeli Society for Cancer Research (ISCR)

Probing the Role of Microglia in Relapsing-Remitting EAE

Zhana Haimon
Immunology, Weizmann Institute of Science, Israel

Microglia are the specialized phagocytes of the brain parenchyma. In multiple sclerosis (MS), an autoimmune disease targeted at the CNS, microglia phagocytose cell debris and upregulate immune-related transcripts. However, it is not clear whether microglia play a beneficial or detrimental role, whether they interact with the infiltrating immune cells and whether or not these cells mediate recovery. Here, we used the Relapsing-Remitting Experimental Autoimmune Encephalomyelitis (RR-EAE) mouse model for MS on SJL*B6 F1 hybrids to study the role of microglia in different stages of the disease, focusing on their contributions to recovery and relapse. Using the RiboTag approach in Cx3cr1CreER:Rpl22HA mice 1, we revealed that microglia actively translate inhibitory molecules, such as Lag3, PDL1 and IL18bp. Moreover, microglia depletion experiments indicate a delayed recovery accompanied by T cell accumulation in the brains. Collectively, our results suggest that the presence and immune competence of microglia might be important for the recovery phase in RR-EAE. Inhibitory molecules expressed by microglia could mediate recovery, however the precise molecular mechanism by which this takes place remains under investigation.









Powered by Eventact EMS